Drilling Tools International Corporation (DTI)

NASDAQ: DTI · Real-Time Price · USD

2.260

+0.090 (4.15%)

At close: Aug 6, 2025, 4:00 PM

2.280

+0.020 (0.88%)

After-hours: Aug 6, 2025, 4:10 PM EDT

Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	160.35	154.45	152.03	129.56	77.38	67.62
Revenue Growth (YoY)	8.19%	1.59%	17.35%	67.43%	14.43%	-
Cost of Revenue	41.2	38.49	35.52	33	23.63	19.72
Gross Profit	119.15	115.96	116.52	96.55	53.75	47.91
Selling, General & Admin	82.36	78.7	68.26	51.57	38.31	40.5
Operating Expenses	107.55	102.53	90.96	71.28	60.03	64.32
Operating Income	11.6	13.43	25.56	25.28	-6.28	-16.41
Interest Expense	-4.5	-3.37	-1.1	-0.48	-1.23	-2.95
Interest & Investment Income	0.28	0.2	0.05	0.05	-	-
Other Non Operating Income (Expenses)	-8.75	-7.7	-4.07	-0.44	-0.23	-0.08
EBT Excluding Unusual Items	-1.36	2.56	20.44	24.42	-7.74	-19.44
Gain (Loss) on Sale of Investments	0.12	0.37	-0.26	0.23	0.16	-0.25
Gain (Loss) on Sale of Assets	0.08	0.06	-0.39	0.13	0.9	-
Asset Writedown	-	-	-	-	-	-3.87
Other Unusual Items	-	-	-	-	8.58	-
Pretax Income	-2.91	2.98	19.79	24.78	1.89	-23.56
Income Tax Expense	-1.13	-0.03	5.05	3.7	-0.21	-5.03
Net Income	-1.78	3.01	14.75	21.08	2.1	-18.53
Preferred Dividends & Other Adjustments	-	-	0.31	1.19	1.12	1.04
Net Income to Common	-1.78	3.01	14.43	19.89	0.98	-19.57
Net Income Growth	-	-79.56%	-30.04%	903.33%	-	-
Shares Outstanding (Basic)	33	32	21	12	52	52
Shares Outstanding (Diluted)	33	32	25	20	52	52
Shares Change (YoY)	20.76%	28.56%	27.71%	-62.42%	-	-
EPS (Basic)	-0.05	0.09	0.67	1.66	0.02	-0.37
EPS (Diluted)	-0.06	0.09	0.59	1.07	0.02	-0.37
EPS Growth	-	-84.66%	-45.22%	5612.54%	-	-
Free Cash Flow	-16.53	-16.83	-20.42	-10.69	-11.88	6.45
Free Cash Flow Per Share	-0.49	-0.52	-0.81	-0.54	-0.23	0.12
Gross Margin	74.31%	75.08%	76.64%	74.52%	69.46%	70.84%
Operating Margin	7.23%	8.69%	16.81%	19.51%	-8.11%	-24.27%
Profit Margin	-1.11%	1.95%	9.49%	15.35%	1.27%	-28.94%
Free Cash Flow Margin	-10.31%	-10.90%	-13.43%	-8.25%	-15.35%	9.53%
EBITDA	36.79	37.26	45.91	44.99	15.44	7.4
EBITDA Margin	22.94%	24.13%	30.20%	34.72%	19.96%	10.95%
D&A For EBITDA	25.19	23.83	20.35	19.71	21.72	23.81
EBIT	11.6	13.43	25.56	25.28	-6.28	-16.41
EBIT Margin	7.23%	8.69%	16.81%	19.51%	-8.11%	-24.27%
Effective Tax Rate	-	-	25.49%	14.92%	-	-
Revenue as Reported	160.35	154.45	152.03	129.56	77.38	67.62

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q